ChemoMetec A/S (CHEMM)

Currency in DKK
682.00
-20.50(-2.92%)
Closed·

CHEMM Income Statement

Period Ending:
2017
30/06
2018
30/06
2019
30/06
2020
30/06
2021
30/06
2022
30/06
2023
30/06
2024
30/06
2025
30/06
2026
30/06
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+32.1%-0.25%+9.78%+15.29%+2.62%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa161.36160.47181.42207.46204.74
aa.aaaa.aaaa.aaaa.aaaa.aa-----
* In Millions of DKK (except for per share items)

FAQ

What was ChemoMetec’s revenue at year end?

At the end of the last reported fiscal year, ChemoMetec (CHEMM) recorded total revenue of 511.06 million DKK.

How much revenue did ChemoMetec report in the most recent quarter?

In its most recent quarterly earnings report, ChemoMetec posted revenue of 262.04 million DKK.

What was ChemoMetec’s net income for the year?

For the full year, ChemoMetec reported net income of 201.84 million DKK.

How much net income did ChemoMetec post in the last quarter?

In the most recent quarter, ChemoMetec (CHEMM) posted net income of 107.86 million DKK.

What was ChemoMetec’s gross profit for the year?

Gross profit for the year was reported at 485.99 million DKK.

How much gross profit did ChemoMetec generate last quarter?

ChemoMetec recorded gross profit of 249.82 million DKK in its latest quarterly report.

What was ChemoMetec’s annual operating income?

For the full year, ChemoMetec (CHEMM) reported operating income of 251.00 million DKK.

What was ChemoMetec’s operating income last quarter?

Quarterly operating income was 130.42 million DKK.

What was ChemoMetec’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 138.42 million DKK.

What was the quarter-over-quarter change in EBITDA for ChemoMetec?

EBITDA changed by 8.59% million DKK compared to the last quarter.

What is ChemoMetec’s most recent gross profit margin?

The latest reported gross profit margin for ChemoMetec (CHEMM) is 95.34% million DKK.

What is ChemoMetec’s most recent net income margin?

Net income margin based on recent financials is 41.16% million DKK.

What is ChemoMetec’s most recent EBIT margin?

ChemoMetec reported an EBIT margin of 49.77% million DKK based on current figures.

How did ChemoMetec’s revenue change compared to the previous quarter?

Revenue changed by 5.23% million DKK compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for ChemoMetec?

In the latest quarter, gross profit changed by 5.78% million DKK from the previous quarter.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.